CATEGORY B · B-35Intermediate

5-((S)-2,2-dimethyltetrahydro2H-pyran-4-yl)-1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro1,2,4-oxadiazol-3-yl) cyclopropyl)-1H-indole-2- carboxylic acid

5-[(S)-2,2-二甲基四氢-2H-吡喃-4-基]-1-[(1S,2S)-2-甲基-1-(5-氧代-4,5-二氢-1,2,4-噁二唑-3-基)环丙基]-1H-吲哚-2-甲酸
CAS Registry No.
2212021-83-3
Terminal API
Omarigliptin
Molecular Weight
411.5
Product Type
Intermediate

Identification & Structure

Chemical structure of 5-((S)-2,2-dimethyltetrahydro2H-pyran-4-yl)-1-((1S,2S)-2-methyl-1-(5-oxo-4,5-dihydro1,2,4-oxadiazol-3-yl) cyclopropyl)-1H-indole-2- carboxylic acid
2D Structure

C[C@H]1C[C@]1(C2=NOC(=O)N2)N3C4=C(C=C(C=C4)[C@H]5CCOC(C5)(C)C)C=C3C(=O)O

Product CodeB-35
Product TypeIntermediate
CAS Number2212021-83-3
Molecular FormulaC22H25N3O5
Molecular Weight411.5
IUPAC Name5-[(4S)-2,2-dimethyloxan-4-yl]-1-[(1S,2S)-2-methyl-1-(5-oxo-4H-1,2,4-oxadiazol-3-yl)cyclopropyl]indole-2-carboxylic acid
SMILESC[C@H]1C[C@]1(C2=NOC(=O)N2)N3C4=C(C=C(C=C4)[C@H]5CCOC(C5)(C)C)C=C3C(=O)O
InChIKeyVWANSYGDVGYGTG-RGDDPNHNSA-N
PubChem CID141723212
Quality ParametersSpecification per batch COA, available on request

Related Terminal API

Listed in our catalog as an intermediate related to Omarigliptin. Specification, available documents and lead time are confirmed with the manufacturer for each inquiry.

Direct Inquiries

Request a Quote & Documents

Tell us the quantity, specification and destination. We will reply by email with pricing, lead time and the documents available.

· Email: inquiry@candidpharm.com
· We will reply by email
· Mutual NDA available on request

Documents on Request

  • Batch Certificate of Analysis (COA)
  • Safety Data Sheet (SDS / MSDS)
  • Regulatory documents, subject to manufacturer

Patent Notice

Products listed on this site that are protected by valid patents are not offered for sale in any country where such sale would infringe those patents. Buyers are solely responsible for determining the patent status of any product in their jurisdiction. Where applicable, supply is limited to research purposes or to jurisdictions in which the relevant patents have expired or do not apply.